Neuroblastoma Screening (PDQ®)–Patient Version
Neuroblastoma screening does reduce the chance of dying from the disease. Not all screening tests are helpful and most have risks. Learn more about neuroblastoma and the potential benefits and harms of screening in this expert-reviewed summary.
Media Type: Html
- SourceUrl: https://www.cancer.gov/node/2497/syndication
- Syndication ID: 1429
- Language: English
- Source: National Cancer Institute (NCI)
- Date Syndication Captured: Saturday, September 14, 2013 at 09:00 AM
- Date Syndication Updated: Saturday, August 29, 2026 at 01:21 AM
Tags
General:
prevention
research
policy
screening
cessation
patient
version
neuroblastoma
secondhand smoke
disease screening
Smoking Use and Tobacco Facts
Quitting Resources
Guidance, Regulations and Compliance
Embed Code Snippet
To get the embed code snippet please Login.
